Close

Press Releases

Cellex gets FDA authorization for COVID-19 antibody test

The agency granted an emergency use authorization to the company for its test, which is meant to detect antibodies against SARS-CoV-2 in the blood. However, antibody testing has both advantages and disadvantages relative to the more common PCR assays. The...

Zymo Research Announces Partnership with Tecan for COVID-19 Viral RNA Extraction

Zymo Research announced a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma, and serum. The DreamPrepโ„ข NAP workstation, featuring Zymo Researchโ€™s Quick-DNA/RNAโ„ข Viral MagBead Kit,...

PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents

PCR Biosystems, the UK-based PCR experts, are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises. To meet current and...

Expert System Grants Researchers Access to AI-Based CRN Tool

Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based Clinical Research Navigator (CRN) tool effective immediately and extending through at least July 1. CRN contains a structured real-time data set of...

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and...

Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology

Ultragenyx Pharmaceutical Inc , a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, announced a strategic partnership and non-exclusive license and technology access agreement with Daiichi Sankyo Company, Limited for...

Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test

Chembio Diagnostics, Inc. , a leading point-of-care diagnostic company focused on infectious diseases, announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies. These results can be obtained within...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป